Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
193.22
+2.26 (1.18%)
At close: Nov 14, 2025, 4:00 PM EST
194.50
+1.28 (0.66%)
After-hours: Nov 14, 2025, 7:34 PM EST
Insmed Stock Forecast
Stock Price Forecast
The 17 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $171.12, which forecasts a -11.44% decrease in the stock price over the next year. The lowest target is $115 and the highest is $240.
Price Target: $171.12 (-11.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 10 | 10 |
| Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Hold | 0 | 0 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $171 → $217 | Buy | Maintains | $171 → $217 | +12.31% | Oct 31, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $196 → $225 | Strong Buy | Maintains | $196 → $225 | +16.45% | Oct 31, 2025 |
| UBS | UBS | Strong Buy Maintains $194 → $223 | Strong Buy | Maintains | $194 → $223 | +15.41% | Oct 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $139 → $215 | Buy | Maintains | $139 → $215 | +11.27% | Oct 31, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $142 → $187 | Strong Buy | Maintains | $142 → $187 | -3.22% | Oct 27, 2025 |
Financial Forecast
Revenue This Year
509.50M
from 363.71M
Increased by 40.09%
Revenue Next Year
1.17B
from 509.50M
Increased by 129.64%
EPS This Year
-6.05
from -5.57
EPS Next Year
-3.64
from -6.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 567.5M | 1.6B | |||
| Avg | 509.5M | 1.2B | |||
| Low | 430.5M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.0% | 207.0% | |||
| Avg | 40.1% | 129.6% | |||
| Low | 18.4% | 73.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.34 | -1.87 | |||
| Avg | -6.05 | -3.64 | |||
| Low | -6.62 | -5.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.